• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TOTAL PSA; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TOTAL PSA; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS Back to Search Results
Catalog Number 08791732190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/01/2021
Event Type  malfunction  
Manufacturer Narrative
The investigation is ongoing.
 
Event Description
There was an allegation of a questionable elecsys total psa immunoassay result for two patients due to interference.Patient 1: the patient had a prostatectomy in 2014 (probably in december).On (b)(6) 2022, the initial result was 0.494 ng/ml and was reported outside of the laboratory.On (b)(6) 2022, the repeat result was 0.475 ng/ml.A separate sample collected on (b)(6) 2022 and repeated three times had a result of < 0.14 ng/ml.This was the expected result for the patient as the previous result for the patient in 2021 was < 0.14 ng/ml.Patient 2: the patient had a probable prostatectomy.The result from a sample in (b)(6) 2021 was < 0.014 ng/ml.The second sample collected in (b)(6) 2021 had a result of 0.446 ng/ml.The repeat result in (b)(6) 2022 was 0.360 ng/ml.The specific dates of testing were not provided.A third sample collected in (b)(6) 2022 had a result of <0.014 ng/ml.This was the expected result for the patient.The questionable results were reported outside of the laboratory.The customer used cobas e 801 module serial number (b)(4).
 
Manufacturer Narrative
As no sample material could be provided for further investigation, the cause of the event could not be determined.The investigation did not identify a product problem.Based on the data and information provided, a general reagent issue can be excluded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TOTAL PSA
Type of Device
PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key14117496
MDR Text Key298203939
Report Number1823260-2022-01056
Device Sequence Number1
Product Code LTJ
UDI-Device Identifier07613336165980
UDI-Public07613336165980
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P990056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 07/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2022
Device Catalogue Number08791732190
Device Lot Number55047201
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/25/2022
Initial Date FDA Received04/15/2022
Supplement Dates Manufacturer Received06/24/2022
Supplement Dates FDA Received07/15/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
PATIENT 1: SUPERDIET QUATUOR
Patient Age69 YR
Patient SexMale
-
-